As of March 2025 Novavax has a market cap of €1.04 Billion. This makes Novavax the world's 5292th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Mar 30th, 2025 the market cap of Novavax was reported to be: